Drugmaker Eli Lilly and Company has quietly settled hundreds of personal injury lawsuits involving patients who claim they experienced withdrawal symptoms while quitting Cymbalta.
When asked for an update on the cases, Robin McCall, media relations director for Baum, Hedlund, Aristei & Goldman, P.C., one of the firms handling the cases, wrote in an email, “All we can say is that the suit has been resolved.”
Lilly is also tight-lipped about the settlement, but provided the following written statement:
“Eli Lilly and Company has reached a comprehensive resolution of all personal injury lawsuits alleging symptoms from discontinuing Lilly’s medication, Cymbalta. Lilly has defended these cases vigorously and has won every case to reach a decision on the merits, including defense verdicts in every trial. To avoid continued legal costs, Lilly reached a resolution with plaintiffs in the remaining cases. Lilly remains committed to Cymbalta and its safety and benefits, which have been repeatedly affirmed by the U.S. Food and Drug Administration.”
No additional details on the settlement were provided.
More
DelMarVa's Premier Source for News, Opinion, Analysis, and Human Interest Contact Publisher Joe Albero at alberobutzo@wmconnect.com or 410-430-5349
I know people who took that drug for several years and had a horrible time coming off of it.
ReplyDeleteEvery Eli Lily board member and its senior staff should take this medication for at least six months, then get back to us on how withdrawal goes for them.
ReplyDeleteWe're looking forward to hearing more news about this. The lawsuits have been going on for almost five years, with the same complaints from up to 40% of patients who have been taking or did take it.
ReplyDelete